Category: General

FDA Draft Guidance: Potentially a Significant Danger

Coalition Defends Use of Rx Data

4A's Urges President and Congress to End Efforts to Remove Drug Ad Deductibility

AMA Rejects Ethics Proposal to Limit Industry Collaboration

AMA CME Speakers Urge Revisions to Proposed CEJA Report